Provided by Tiger Trade Technology Pte. Ltd.

ARS PHARMACEUTICALS INC

5.06
-0.1700-3.25%
Volume:1.09M
Turnover:5.55M
Market Cap:503.20M
PE:-2.33
High:5.22
Open:5.20
Low:5.02
Close:5.23
52wk High:13.15
52wk Low:4.91
Shares:99.45M
Float Shares:48.03M
Volume Ratio:1.07
T/O Rate:2.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1757
EPS(LYR):-1.7400
ROE:-210.35%
ROA:-48.02%
PB:40.22
PE(LYR):-2.91

Loading ...

ARS Pharmaceuticals Q1 revenue beats estimates on neffy sales growth

Reuters
·
May 15

Earnings Flash (SPRY) ARS Pharmaceuticals Posts Q1 Loss $0.61 a Share, vs. FactSet Est of $0.49 Loss

MT Newswires Live
·
May 15

ARS Pharmaceuticals Q1 EPS $(0.61) Misses $(0.52) Estimate, Sales $22.681M Beat $22.230M Estimate

Benzinga Earnings
·
May 15

ARS Pharmaceuticals: Anticipate Majority of Medicaid State Plans Adopting Neffy to Their Unrestricted Medicaid Formularies by Early 2027

THOMSON REUTERS
·
May 15

ARS Pharmaceuticals Q1 Net Income USD -60.618 Million

THOMSON REUTERS
·
May 15

ARS Pharmaceuticals Q1 Cash & Investments USD 201 Million

THOMSON REUTERS
·
May 15

ARS Pharmaceuticals Inc: CVS Caremark Proposal in Final Stages of Approval Process; Definitive Update Anticipated in Early June

THOMSON REUTERS
·
May 15

ARS Pharmaceuticals Q1 EPS USD -0.61

THOMSON REUTERS
·
May 15

ARS Pharmaceuticals Q1 Revenue USD 22.7 Million VS. Ibes Estimate USD 22.2 Million

THOMSON REUTERS
·
May 15

Press Release: ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update

Dow Jones
·
May 15

U.S. Earnings Preview: Before Market Open May 15

Dow Jones
·
May 15

ARS Pharmaceuticals Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Benzinga Earnings
·
May 15

Dow Settles Above 50,000: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone

Benzinga Earnings
·
May 15

Top News Today: Stocks Rise as Cerebras IPO Stokes AI Euphoria

Dow Jones
·
May 15

ARS Pharmaceuticals Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
May 13

ARS Pharma names Donn Casale president, effective June 1

Reuters
·
May 13

ARS Pharmaceuticals Strengthens Leadership Team With Appointment of Industry Veteran Donn Casale as President

THOMSON REUTERS
·
May 13

ARS Pharma to host Q1 2026 results conference call, webcast

Reuters
·
May 07

ARS Pharmaceuticals announces annual shareholder meeting notice

Reuters
·
Apr 30

BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems

Reuters
·
Apr 16